M. V. Lopukhina

M. V. Lopukhina

Auto-generated profile, based on publicly available information

M. V. Lopukhina

Municipal Clinical Hospital No. 15 named after O.M. Filatov

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ОOО. D. Ostroumova
О. D. Ostroumova
AKA. I. Kochetkov
A. I. Kochetkov
MLM. V. Lopukhina
M. V. Lopukhina
EPE. Е. Pavleeva
E. Е. Pavleeva
The review is focused on clinical significance of the left ventricle hypertrophy (LVH) — presentation of heart lesion as a target organ for systemic hypertension (SH). Various LVH development mechanisms are presented, and special attention is paid to sympathic nervous system and β-adrenoreceptors in pathogenesis. Fundamental methods of diagnostics are described for LVH, in comparison. The pathology is classified from the perspective of recent guidelines on echocardiographic diagnostics. Epidemiology provided. Taken current evidence, the prognostic role of LVH is described as a factor increasing the risk of fatal and non-fatal cardiovascular, cerebrovascular and renal complications in SH patients. Trials data presented that points on LVH regression with highly selective β1-blocker bisoprolol treatment. Pathophysiology of LVH regression is discussed for β1-blocker treatment.

19 May 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
AKA. I. Kochetkov
A. I. Kochetkov
IOI. Yu. Orlova
I. Yu. Orlova
OOO. D. Ostroumova
O. D. Ostroumova
MLM. V. Lopukhina
M. V. Lopukhina
ASAntonina Vladimirovna Starodubova
Antonina Vladimirovna Starodubova
AAA. I. Andrianov
A. I. Andrianov
Introduction. Myocardial fibrosis is often found in atrial fibrillation (AF), but there are no data on its relationship with structural and functional heart damage in various forms of the latter.Aim. To determine the possible relationship between echocardiographic parameters and blood levels of cardiac fibrosis markers (C-terminal propeptide of procollagen type 1, PICP; N-terminal propeptide of procollagen type 1, P3NP; galectin 3; transforming growth factor beta 1, TGF-β1) in patients with different forms of AF.Materials and methods. The study included 50 patients with paroxysmal AF (median age 73 [65.8;76] years, 34 (68%) women) and 34 patients with persistent/permanent forms of AF (median age 77.5 [67.5;81.3] years, 21 (62%) women). Transthoracic echocardiography was performed in all patients using the speckle tracking technique and serum levels of PICP, P3NP, galectin 3 and TGF-β1 were determined.Results. Serum P3NP correlate with E/e’ media (p=0.048, R2 = 0.117) in patients with persistent/permanent forms of AF. PICP level correlated with the average strain of the left atrium (LA) in patients with persistent/permanent forms of AF (p = 0.01, R2 = 0.189). The blood level of galectin 3 correlated with E/e’ media in the general cohort of patients with AF and in the group of patients with persistent/permanent forms of AF (p = 0.005, R2 = 0.095 and p = 0.027, R2 = 0.144, respectively), and with global longitudinal strain of the left ventricle (LV) – in the group of patients with paroxysmal AF (p = 0.044, R2 = 0.084). The serum TGF-β1 correlated with E/e’ media (p = 0.013, R2 = 0.074) in the general cohort of patients with AF and with values of the global longitudinal LV strain (p = 0.027, R2 = 0.099) in the group of patients with paroxysmal AF.Conclusions. Serum levels of PICP, P3NP, galectin-3 and TGF-β1 correlate with the values of E/e’ media, global longitudinal LV strain and average LA strain. An integrated approach, including standard echocardiography, Speckle Tracking echocardiography, and determination of the level of fibrosis biomarkers in the blood can help to more accurately assess the degree of cardiac fibrosis in a noninvasive way in patients with various forms of AF.

6 March 2024 in Лечащий врач
Verified
Journal Article
Closed access
AKA.I. Kochetkov
A.I. Kochetkov
IOI.YU. Orlovа
I.YU. Orlovа
OOO.D. Ostroumovа
O.D. Ostroumovа
VDV.B. Dashabylova
V.B. Dashabylova
MLM.V. Lopukhinа
M.V. Lopukhinа
GPG.F. Piksina
G.F. Piksina
Objective. The purpose of this study was to compare the structural and functional changes of the left ventricle (LV) in patients with various forms of atrial fibrillation (AF). Materials and methods. 70 patients with paroxysmal AF (group 1; median age 73 [64.75; 76.5] years, 49 (70%) women) and 54 patients with persistent or permanent forms of AF (group 2; median age 78.5 [68;83] years, 33 (61%) women) was included in the study/ All patients were underwent transthoracic echocardiography (EchoCG) using the speckle tracking technique. Results. In patients with permanent/persistent AF, compared with patients with paroxysmal AF, the several parametres were significantly lower: the stroke volume (SV) (49.2 [39.8; 57.8] ml versus 54.2 [46.2; 60.3] ml, respectively, p = 0.039), LV ejection fraction (EF) (61.4% [51.2; 67.1] versus 65.9% [61.4; 70.2], respectively, p < 0.001), absolute values of the global longitudinal LV strain (–15.1% [–18.5; –9.3] vs. –19.6% [–22.2; –16.2] respectively, p < 0.001), global LV circular strain (–16.4% [–22.9; –11.0] vs. –20.9% [–25.8; –17.6], respectively, p < 0.001), end-systolic LV elasticity (3.6 [2.7; 4.57] mmHg/ml vs. 4.3 [3.3; 5.3] mmHg/ml, respectively, p = 0.011). At the same time, the end-diastolic size (EDS), the end-diastolic volume (EDV) and its index, and the end-systolic volume (ESV) did not differ statistically significantly between the groups. Conclusion. In patients with persistent/permanent forms of AF, there is a more pronounced violation of LV systolic function compared with patients with paroxysmal AF, which manifests itself in lower values of SV, LV EF, absolute values of the global longitudinal strain and global circular strain of the LV.

25 June 2026 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
LGL. V. Glukhacheva
L. V. Glukhacheva
OOO. D. Ostroumova
O. D. Ostroumova
ATA. A. Tyazhelnikov
A. A. Tyazhelnikov
AKA. I. Kochetkov
A. I. Kochetkov
TOT. M. Ostroumova
T. M. Ostroumova
СТС. С. Телкова
С. С. Телкова
Introduction. Atrial fibrillation (AF) is an independent risk factor for cognitive decline (CD). However, the role of iron deficiency (ID) and anemia as modifiable factors exacerbating cognitive impairment in this issue remains understudied. Aim. To assess the impact of anemia/ID on the condition of cognitive functions young and middle age patients with AF. Mat erials and methods. This cross-sectional study included 45 patients with AF (median age 53.2 [50.4; 57.2] years), divided into two groups: with anemia and/or ID (n = 23) and without (n = 22). Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE), Trail Making Test (Parts A & B), Verbal Fluency Test, Word-List Recall, Stroop Test, Digit Span Test, and Digit Symbol Substitution Test (DSST). Anxiety and depression levels were evaluated using the Beck Anxiety Inventory (BAI) and Hamilton Depression Rating Scale (HDRS). Results. Compared to patients without anemia/ID, patients with AF and anemia/ID demonstrated significantly lower total scores on the MoCA (26 [25; 27] vs 28 [27; 28.5] points, p < 0.001) and MMSE (26 [25; 26] vs 28 [28; 29] points, p < 0.001). They also showed reduced performance in immediate word recall (4 [4; 5] vs 5 [5; 5.3] words, p = 0.032), delayed recall (3 [3; 3.3] vs 4 [4; 5] words, p < 0.001), and the letter fluency test (13 [12.8; 14] vs 14 [13; 15] words, p = 0.013). Psychomotor speed was slower on the DSST (46 [41; 50] vs 55 [44.8; 65] points, p = 0.011), attention was worse on the Digit Span Test (4 [4; 4.3] vs 5 [4.8; 5.3] points, p = 0.005), and execution time was longer for Trail Making Test Part A (61.5 [57.8; 63.8] vs 50 [45; 57.3] s, p < 0.001) and Part B (79.5 [74; 92] vs 69 [64; 77] s, p < 0.001). Conclusions. Anemia/ID in young and middle-aged patients with AF is associated with multiple cognitive deficits, which justifies the need for screening of iron metabolism and hemoglobin levels in this patient population.

25 October 2026 in Medical alphabet
Verified
Journal Article
Open access
PDF file
LGL. V. Glukhacheva
L. V. Glukhacheva
OOO. D. Ostroumova
O. D. Ostroumova
ASA. Ya. Starokozheva
A. Ya. Starokozheva
AKA. I. Kochetkov
A. I. Kochetkov
GPG. F. Piksina
G. F. Piksina
СТС. С. Телкова
С. С. Телкова
Background. The clinical significance of anemia and iron deficiency (ID) in patients with atrial fibrillation (AF) is currently undetermined and requires further investigation. Objective. Analysis of the effect of anemia/ID on physical performance and quality of life in young and middle-aged patients with AF. Materials and methods. This cross-sectional, comparative study included 45 patients with AF (84.4 % male), who were divided into two groups: those with anemia and/or ID (n=23) and those without these conditions (n=22). Physical performance was assessed using a treadmill test and the six-minute walk test, while quality of life was evaluated using the SF-36 questionnaire. Results. Patients with AF and anemia/ID demonstrated lower peak exercise capacity compared to those without these conditions (4.8 [3.2; 5.5] vs. 7.0 [6.2; 9.2] METs, p<0.001); a higher proportion of patients without anemia/ID reached submaximal heart rate compared to those with anemia/ID (59 % and 22 %, respectively, p=0.028). A greater number of patients in the anemia/ID group exhibited low exercise tolerance compared to the nonanemic/non-ID group (70 % and 27 %, respectively, p=0.006). In the six-minute walk test, patients with anemia/ID covered a shorter distance than those without anemia/ID (765 [697.5; 837.5] vs. 905 [857; 995] meters, p<0.001). In patients with AF and anemia/ID, the final score for the Physical Component Summary (PCS) of health was statistically significantly lower compared to the group without anemia/ID (45.5 [39.7; 49.8] vs. 55 [45; 58] points, p=0.007). A similar result was observed when assessing the Mental Component Summary (MCS) of health (38 [33.5; 44.5] vs. 45 [40.8; 49] points, p=0.024). Conclusions. In young and middle-aged patients with AF, the presence of anemia and/or ID leads to decreased physical performance and reduced quality of life.